| 000 | 01760 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250516141339.0 | ||
| 264 | 0 | _c20131126 | |
| 008 | 201311s 0 0 eng d | ||
| 022 | _a1090-2430 | ||
| 024 | 7 |
_a10.1016/j.expneurol.2013.03.002 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFrau, Lucia | |
| 245 | 0 | 0 |
_aPerformance of movement in hemiparkinsonian rats influences the modifications induced by dopamine agonists in striatal efferent dynorphinergic neurons. _h[electronic resource] |
| 260 |
_bExperimental neurology _cSep 2013 |
||
| 300 |
_a663-72 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_a2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine _xpharmacology |
| 650 | 0 | 4 |
_aAdrenergic Agents _xtoxicity |
| 650 | 0 | 4 | _aAnalysis of Variance |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aApomorphine _xpharmacology |
| 650 | 0 | 4 |
_aCorpus Striatum _xdrug effects |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aDopamine Agonists _xpharmacology |
| 650 | 0 | 4 |
_aDynorphins _xmetabolism |
| 650 | 0 | 4 |
_aEarly Growth Response Protein 1 _xgenetics |
| 650 | 0 | 4 |
_aEnkephalins _xgenetics |
| 650 | 0 | 4 |
_aFunctional Laterality _xdrug effects |
| 650 | 0 | 4 |
_aGene Expression Regulation _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMotor Neurons |
| 650 | 0 | 4 |
_aMovement _xphysiology |
| 650 | 0 | 4 |
_aOxidopamine _xtoxicity |
| 650 | 0 | 4 |
_aParkinson Disease _xetiology |
| 650 | 0 | 4 | _aRNA, Messenger |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 700 | 1 | _aMorelli, Micaela | |
| 700 | 1 | _aSimola, Nicola | |
| 773 | 0 |
_tExperimental neurology _gvol. 247 _gp. 663-72 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.expneurol.2013.03.002 _zAvailable from publisher's website |
| 999 |
_c22588678 _d22588678 |
||